Autism spectrum disorders and atopic dermatitis: a new perspective from country-based prevalence data.

Atopic dermatitis Atopy Autism spectrum disorders Immune system Neurodevelopmental disorders

Journal

Clinical and molecular allergy : CMA
ISSN: 1476-7961
Titre abrégé: Clin Mol Allergy
Pays: England
ID NLM: 101152195

Informations de publication

Date de publication:
20 Dec 2021
Historique:
received: 27 09 2021
accepted: 02 12 2021
entrez: 21 12 2021
pubmed: 22 12 2021
medline: 22 12 2021
Statut: epublish

Résumé

Recently, a continuous growth for both neurodevelopmental and atopic diseases' incidence was seen throughout the world. Notably, autism spectrum disorders (ASD) and atopic dermatitis (AD) attracted the attention of clinicians and scientists for their impact on the quality of life of patients, starting during childhood. Despite a number of hypotheses about common pathogenesis between the two disorders, uncertainty is still present, and data coming from various parts of the world are contradictory. Fortunately, works recently published have brought useful material for comparative analysis to the benefit of the scientific community, making large scale, country-based perspectives methodologically viable. In light of that, the present study took into account uniform data, available from country-based registries or related publications, dealing with the prevalence of the two conditions around the world, and tried to setup a simple correlation analysis between the two. According to such data, the growth of AD and ASD prevalence appear uncorrelated, leading to hypothesise that, if a common etiopathological pathway exists between the two conditions, they are likely to interact to each other due to a complex interplay of co-morbidities, genes and environmental players not enough explained by a simple correlation analysis. Such facts are worth investigation in future research.

Identifiants

pubmed: 34930274
doi: 10.1186/s12948-021-00166-5
pii: 10.1186/s12948-021-00166-5
pmc: PMC8691085
doi:

Types de publication

Journal Article

Langues

eng

Pagination

27

Informations de copyright

© 2021. The Author(s).

Références

Nutrients. 2020 Dec 29;13(1):
pubmed: 33383952
Allergol Immunopathol (Madr). 2021 May 01;49(3):162-168
pubmed: 33938202
Nutrients. 2021 Jan 08;13(1):
pubmed: 33435598
Br J Dermatol. 2021 Feb;184(2):304-309
pubmed: 33006135
J Chin Med Assoc. 2018 Aug;81(8):729-734
pubmed: 29459223
Front Psychiatry. 2020 Jan 31;10:987
pubmed: 32082196
Adv Exp Med Biol. 2020;1253:107-140
pubmed: 32445093
Expert Rev Clin Immunol. 2017 Jan;13(1):15-26
pubmed: 27417220
Lancet. 2006 Aug 26;368(9537):733-43
pubmed: 16935684
Allergol Immunopathol (Madr). 2021 Mar 01;49(2):66-71
pubmed: 33641296
Allergy. 2010 Dec;65(12):1506-24
pubmed: 20716320
J Clin Med. 2019 Jan 14;8(1):
pubmed: 30646527
Biochim Biophys Acta. 2012 Jun;1822(6):831-42
pubmed: 22326556
JAMA. 2018 Jan 2;319(1):81-82
pubmed: 29297068
J Clin Cell Immunol. 2014 Apr;5(2):
pubmed: 25419479
Pediatr Neurol. 2005 Sep;33(3):195-201
pubmed: 16139734
Curr Opin Neurol. 2010 Apr;23(2):103-10
pubmed: 20087183
J Pediatr. 2016 Apr;171:248-55
pubmed: 26846570
Am J Clin Dermatol. 2015 Oct;16(5):371-88
pubmed: 26254000
JAMA Psychiatry. 2019 Oct 1;76(10):1035-1043
pubmed: 31314057
J Autism Dev Disord. 2019 Nov;49(11):4626-4633
pubmed: 31435817
Neuropsychiatr Dis Treat. 2019 May 28;15:1469-1478
pubmed: 31239682
Bone Rep. 2018 Mar 17;8:135-146
pubmed: 29955632
Medicine (Baltimore). 2016 Sep;95(39):e5005
pubmed: 27684861
Minerva Pediatr. 2017 Dec;69(6):538-550
pubmed: 27706122

Auteurs

Alessandro Tonacci (A)

Clinical Physiology Institute, National Research Council of Italy (IFC-CNR), Via Moruzzi 1, 56124, Pisa, Italy. atonacci@ifc.cnr.it.

Giovanni Pioggia (G)

Institute for Biomedical Research and Innovation, National Research Council of Italy (IRIB-CNR), 98164, Messina, Italy.

Sebastiano Gangemi (S)

Department of Clinical and Experimental Medicine, School and Operative Unit of Allergy and Clinical Immunology, University of Messina, 98125, Messina, Italy.

Classifications MeSH